Home Faculty IQ Test Crossword Podcast Whiteboards

RA Quality Measures

Faculty


Robin K. Dore, MD
Clinical Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

Max Hamburger, MD
Managing Partner
Rheumatology Associates of Long Island
Assistant Professor, Clinical Medicine
SUNY Stony Brook
Melville, New York

Arthur Kavanaugh, MD
Professor of Clinical Medicine
Director Center for Innovative Therapy (CIT)
University of California, San Diego
La Jolla, California

Jonathan Kay, MD
Professor of Medicine
University of Massachusetts Medical School
Worcester, Massachusetts

Eric Ruderman, MD
Professor in Medicine, Rheumatology
Northwestern University
Feinberg School of Medicine
Chicago, Illinois

Kenneth S. Saag, MD, MSc
Professor of Medicine, Division of Clinical Immunology and Rheumatology
University of Alabama at Birmingham (UAB) School of Medicine
Professor of Epidemiology
UAB School of Public Health
Birmingham, Alabama

Vibeke Strand, MD, MACR, FACP
Adjunct Clinical Professor
Division of Immunology/Rheumatology
Stanford University
Portola Valley, California

Michael Weisman, MD
Director, Division of Rheumatology
Professor of Medicine
Chair in Rheumatology
Cedars-Sinai Medical Center
Los Angeles, California


PLANNERS
Michael Weisman, MD

Director, Division of Rheumatology
Professor of Medicine
Chair in Rheumatology
Cedars-Sinai Medical Center

Ani Mardakhanian, MHA
CME Program Specialist for Strategic Alliances and Programing
Continuing Medical Education
Cedars-Sinai Medical Center

Megan Swartz
Manager, Office of Continuing Medical Education
Cedars-Sinai Medical Center

Daniel Rabin, PhD
Medical Director
The France Foundation

Heather Tarbox, MPH
Director of Education
The France Foundation

Amanda Noe
Senior Project Manager
The France Foundation


Disclosure of Potential Conflicts of Interest
It is the policy of Cedars-Sinai Medical Center to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Cedars-Sinai Medical Center assesses conflict of interest with its faculty, planners and managers of CME activities. Conflicts of interest that are identified are resolved by reviewing that presenter’s content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and patient care recommendations.

While Cedars-Sinai Medical Center endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.

In accordance with the policy of Cedars-Sinai, faculty are asked to disclose any affiliation or financial interest that may affect the content of their presentations. The faculty reported the following:

Name of Individual

Individual’s Role in Activity

Name of Commercial Interest

Nature of Relationship

Max Hamburger, MD

Faculty

Abbvie, BMS, Crescendo, UCB

Speakers Bureau

Eric Ruderman, MD

Faculty

AbbVie, Amgen, Janssen, Lilly, Medac, Novartis, Pfizer

AbGenomics, AbbVie, Amgen, Pfizer

Consulting fee


Contracted research

Kenneth S. Saag, MD, MSc

Faculty

Abbott, Amgen, Ardea/AstraZeneca, BMS, Lilly, Merck, Pfizer, Roche/Genentech

Consulting fee

Vibeke Strand, MD, MACR, FACP

Faculty

Abbvie, Afferent, Alder, Amgen Corporation, Anthera, AstraZeneca, aTyr, BiogenIdec, Biotest, Bioventus, BMS,
Boehringer Ingelheim, Carbylan, Celgene, Celltrion, CORRONA, Crescendo/Myriad Genetics, Daiichi Sankyo, EMD Serono, Eupraxia, Genentech/Roche, GlaxoSmithKline, Iroko, Janssen, Jazz Pharmaceuticals, Kypha, Lilly, Novartis, Pfizer, Protagen, Regeneron, Sandoz, Sanofi, SKK, UCB, Vertex

Abbvie, Amgen, BiogenIdec, BMS, Carbylan, Crescendo, Genentech/Roche, GlaxoSmithKline, Iroko, Janssen, Jazz, Lilly, MerckSerono, Novartis, Pfizer, Regeneron, Sandoz, Sanofi, UCB

Consulting fee

 

 

 

 


Advisory Board

Robin K. Dore, MD

Faculty

None

Jonathan Kay, MD

Faculty

AbbVie Inc, Amgen Inc; AstraZeneca; Boehringer Ingelheim GmbH; Bristol-Myers Squibb Company, Crescendo Bioscience, Inc.; Eli Lilly and Company; Epirus Biopharmaceuticals, Inc.; Genentech Inc.; GlaxoSmithKline PLC; Hospira, Inc.; Janssen Biotech, Inc.; Merck Sharp & Dohme Corp.; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Roche Laboratories, Inc.; Samsumg Bioepis; Sandoz Inc.; UCB, Inc.

University of Massachusetts Medical School: AbbVie Inc.; Eli Lilly and Company; Genentech Inc.; Pfizer, Inc.; Roche Laboratories, Inc.

Consulting Fee

 

 

 

 



Contracted Research


The independent reviewer and following planners had no relevant conflicts of interest to report: Michael Weisman, MD, Ani Mardakhanian, MHA, Megan Swartz, Daniel Rabin, PhD, Heather Tarbox, MPH, Amanda Noe.